Host cytokine response and resistance to Salmonella infection

Microbes and Infection

Volumn 1, Issue 9, 1999, Pages 719-726

  Lalmanach, Anne Christine ^a   Lantier, Frédéric ^a  

^a CEMAGREF   (France)

Author keywords

Cytokines; Disease susceptibility; Genetics; Macrophages; Natural immunity; Salmonella infections animal

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 6; RECOMBINANT GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ANTIBACTERIAL ACTIVITY; DISEASE PREDISPOSITION; GENETIC SUSCEPTIBILITY; IMMUNE RESPONSE; INFECTION RESISTANCE; MACROPHAGE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SALMONELLA; SALMONELLOSIS;

ANIMALIA; NEGIBACTERIA; SALMONELLA;

EID: 0032693937     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(99)80073-2     Document Type: Review

References (82)

1. Meslin F.X. Global aspects of emerging and potential zoonoses: a WHO perspective. Emerg. Infect. Dis. 2:1997;223-228.
2. Kaufmann S.H.E. Immunity to intracellular bacteria. Ann. Rev. Immunol. 11:1993;129-163.
3. Liles W.C., VanVoorhis W.C. Review: nomenclature and biologic significance of cytokines involved in inflammation and the host immune response. J. Infect. Dis. 172:1995;1573-1580.
4. Lin R., Tarr P.E., Jones T.C. Present status of the use of cytokines as adjuvants with vaccines to protect against infectious dieases. Clin. Infect. Dis. 21:1995;1439-1449.
5. Mastroeni P., Harrison J.A., Hormaeche C.E. Natural resistance and acquired immunity to Salmonella. Fund. Clin. Immunol. 2:1994;83-95.
6. Jones B.D., Falkow S. Salmonellosis: host immune responses and bacterial virulence determinants. Annu. Rev. Immunol. 14:1996;533-561.
7. Berthon P., Bernard S., Lantier F. Immunohistochemical studies of sheep lymph nodes after subcutaneous inoculation of Salmonella abortusovis. Gershwin L, Lunney J, Schore C. Proceedings of the Fourth International Veterinary Immunology Symposium. 1995;269 University of California, Davis.
8. Gohin I., Olivier M., Lantier I., Pepin M., Lantier F. Analysis of the immune response in sheep efferent lymph during Salmonella abortusovis infection. Vet. Immunol. Immunopathol. 60:1997;111-130.
9. Mastroeni P., Villareal-Ramos B., Hormaeche C.E. Adoptive transfer of immunity to oral challenge with virulent Salmonellae in innately susceptible BALB/c mice requires both immune serum and T cells. Infect. Immun. 61:1993;3981-3984.
10. Lantier F., Pardon P., Marly J. Immunogenicity of a low-virulence vaccinal strain against Salmonella abortus-ovis infection in mice. Infect. Immun. 40:1983;601-607.
11. Eisenstein T.K., Killar L.M., Sultzer B.M. Immunity to infection with Salmonella typhimurium: mouse strain differences in vaccine- and serum-mediated protection. J. Infect. Dis. 150:1984;425.
12. Malo D., Skamene E. Genetic control of host resistance to infection. Trends Genet. 10:1994;365-371.
13. Skamene E., Schurr E., Gros P. Infection genomics: Nramp1 as a major determinant of natural resistance to intracellular infections. Annu. Rev. M. 49:1998;275-287.
14. Govoni G., Gauthier S., Billia F., Iscove N.N., Gros P. Cell-specific and inducible Nramp1 gene expression in mouse macrophages in vitro and in vivo. J. Leukoc. Biol. 62:1997;277-286.
15. Bussmann V., Lantier I., Pitel F. cDNA cloning structural organization and expression of the sheep NRAMP1 gene. Mamm. Gen. 1998;1027-1031.
16. Hu J., Bumstead N., Skamene E., Gros P., Malo D. Structural organization, sequence and expression of the chicken NRAMP1 gene encoding the natural resistance-associated macrophage protein 1 DNA. Cell Biol. 15:1996;113-123.
17. Feng J., Li Y., Hashad M. Bovine natural resistance associated macrophage protein 1 (Nramp1) gene. Genome Res. 6:1996;956-964.
18. Gruner L., Lantier F. Breeding for resistance to infectious diseases of small ruminants in Europe. Gray G.D, Woolaston R.R, Eaton B.T. Breeding for resistance to infectious dideases in small ruminants. 1995;99-117 Australian Center for International Agricultural Research Canberra, Australia.
19. DeJong R., Altare F., Haagen I.A. et al. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science. 280:1998;1435-1438.
20. Henderson B., Poole S., Wilson M. Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol. Rev. 60:1996;316-341.
21. Wilson M., Seymour R., Henderson B. Bacterial perturbation of cytokine networks. Infect. Immun. 66:1998;2401-2409.
22. Ciacci-Woolwine F., Blomfield I.C., Richardson S.H., Mizel S.B. Salmonella flagellin induces tumour necrosis factor alpha in a human promonocytic cell line. Infect. Immun. 66:1998;1127-1134.
23. Mosmann T.R., Coffman R.L. Th1 and Th2 cells: different patterns of lymphokine secretions lead to different functionnal properties. Annu. Rev. Immunol. 7:1989;145-173.
24. Sher A., Coffman R.L. Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu. Rev. Immunol. 10:1992;385-409.
25. Soo S.S., Villareaol-Ramos B., AnjamKhan C.M., Hormaeche C.E., Blackwell J.M. Genetic control of immune response to recombinant antigens carried by an attenuated Salmonella typhimurium vaccine strain: Nramp1 influences T-helper subset responses and protection against leishmanial challenge. Infect. Immun. 66:1998;1910-1917.
26. + T cells producing IL-4 may be involved in the increased susceptibility of mice with the beige mutation during Salmonella infection. J. Immunol. 158:1997;2268-2277.
27. Ramarathinam L., Shaban R.A., Niesel D.W., Klimpel G.R. IFN-γ production by gut-associated lymphoid tissue and spleen following oral S. typhimurium challenge. Microb. Pathogen. 11:1991;347-356.
28. Kumazawa Y., Freudenberg M., Hausmann C., Meding-Slade S., Langhorne J., Galanos C. Formation of interferon-gamma and tumour necrosis factor in mice during Salmonella typhimurium infection. Pathobiology. 59:1991;194-196.
29. Sztein M.B., Wasserman S.S., Tacket C.O., Edelman R., Hone D., Lindberg A.A., Levine M.M. Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi. J. Infect. Dis. 170:1994;1508-1517.
30. Muotiala A., Mäkelä P.H. The role of IFN-γ in murine Salmonella typhimurium infection. Microb. Pathogen. 8:1990;135-141.
31. Gould C.L., Sonnenfeld G. Effect of treatment with interferon-γ and concanavalin A on the course of infection of mice with Salmonella typhimurium strain LT-2. J. Interferon Res. 7:1987;255-260.
32. Edwards C.K. III, Ghiasuddin S.M., Yunger L.M., Lorence R.M., Arkins S., Dantzer R., Kelley K.W. In vivo administration of recombinant growth hormone or gamma interferon activates macrophages: enhanced resistance to experimental Salmonella typhimurium infection is correlated with generation of reactive oxygen intermediates. Infect. Immun. 60:1992;2514-2521.
33. Van Dissel J.T., Stikkelbroeck J.J.M., Michel B.C., Van Den Barselaar M.T., Leijh P.C.J., VanFurth R. Inability of recombinant interferon-γ to activate the antibacterial activity of mouse peritoneal macrophages against Listeria monocytogenes and Salmonella typhimurium. J. Immunol. 139:1987;1673-1678.
34. Kagaya K., Watanabe K., Fukazawa Y. Capacity of recombinant gamma interferon to activate macrophages for Salmonella-killing activity. Infect. Immun. 57:1989;609-615.
35. Nauciel C., Espinasse-Maes F. Role of gamma interferon and tumour necrosis factor alpha in resistance to Salmonella typhimurium infection. Infect. Immun. 60:1992;450-454.
36. Gulig P.A., Doyle T.J., Clare-Salzler M.J., Maiese R.L., Matsui H. Systemic infection of mice by wild-type but not spv- Salmonella typhimurium is enhanced by neutralization of gamma interferon and tumour necrosis factor alpha. Infect. Immun. 65:1997;5191-5197.
37. Hess J., Ladel C., Miko D., Kaufmann S.H.E. Salmonella typhimurium aroA- infection in gene-targeted immunodeficient mice. J. Immunol. 156:1996;3321-3326.
38. Eckmann L., Fierer J., Kagnoff M.F. Genetically resistant (Ityr) and susceptible (Itys) congenic mouse strains show similar cytokine responses following infection with Salmonella dublin. J. Immunol. 156:1996;2894-2900.
39. Pie S., Matsiota-Bernard P., Truffa-Bachi P., Nauciel C. Gamma interferon and interleukin-10 gene expression in innately susceptible and resistant mice during the early phase of Salmonella typhimurium infection. Infect. Immun. 64:1996;849-854.
40. Kita E., Emoto M., Oku D., Nishikawa F., Hamuro A., Kamikaidou N., Kashiba S. Contribution of interferon γ and membrane-associated interleukin 1 to the resistance to murine typhoid of Ityr mice. J. Leukoc. Biol. 51:1992;244-250.
41. Ramarathinam L., Niesel D.W., Klimpel G.R. Ity influences the production of IFN-γ by murine splenocytes stimulated in vitro with Salmonella typhimurium. J. Immunol. 150:1993;3965-3972.
42. Benbernou N., Nauciel C. Influence of mouse genotype and bacterial virulence in the generation of interferon-γ-producing cells during the early phase of Salmonella typhimurium infection. Immunology. 83:1994;245-249.
43. Jouanguy E., Lamhamedi-Cherradi S., Altare F. Partial interferon-γ receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis. J. Clin. Invest. 100:1997;2658-2664.
44. Mastroeni P., Clare S., Khan J.A. Interleukin 18 contributes to host resistance and gamma interferon production in mice infected with virulent Salmonella typhimurium. Infect. Immun. 67:1999;478-483.
45. Chan S.H., Perussia B., Gupta J.W. Induction of interferon-γ production by natural killer cell stimulatory factor: characterization of the responding cells and synergy with others inducers. J. Exp. M. 173:1991;869-879.
46. Wolf S.F., Temple P.A., Kobayashi M. et al. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J. Immunol. 146:1991;3074-3081.
47. Heinzel F.P., Rerko R.M., Ling P., Hakimi J., Shoenhaut D.S. Interleukin 12 is produced in vivo during endotoxemia and stimulates synthesis of gamma interferon. Infect. Immun. 62:1994;4244-4249.
48. Bost K.L., Clements J.D. In vivo induction of interleukin-12 mRNA expression after oral immunization with Salmonella dublin or the B subunit of Escherichia coli heat-labile enterotoxin. Infect. Immun. 63:1995;1076-1083.
49. Kincy-Cain T., Clements J.D., Bost K.L. Endogenous and Exogenous interleukin-12 augment the protective immune response in mice orally challenged with Salmonella dublin. Infect. Immun. 64:1996;1437-1440.
50. Mastroeni P., Harrison J.A., Chabalgoity J.A., Hormaeche C.E. Effect of interleukin 12 neutralization on host resistance and gamma interferon production in mouse typhoid. Infect. Immun. 64:1996;189-196.
51. Chong C., Bost K.L., Clements J.D. Differential production of interleukin-12 mRNA by murine macrophages in response to viable or killed Salmonella spp. Infect. Immun. 64:1996;1154-1160.
52. Bost K.L., Clements J.D. Intracellular Salmonella dublin induces substantial secretion of the 40-kilodalton subunit of interleukin-12 (IL-12) but minimal secretion of IL-12 as a 70-kilodalton protein in murine macrophages. Infect. Immun. 65:1997;3186-3192.
53. Mastroeni P., Harrison J.A., Robinson J.H. et al. Interleukin-12 is required for control of the growth of attenuated aromatic-compound-dependent Salmonellae in BALB/c mice: role of gamma interferon and macrophage activation. Infect. Immun. 66:1998;4767-4776.
54. Cannon J.G., Tompkins R.G., Gelfland J.A. Circulating interleukin 1 and tumor necrosis factor in septic shock and experimental fever. J. Infect. Dis. 161:1990;79-84.
55. Shibuya K., Robinson D., Zonin F. IL-1α and TNF-α are required for IL-12-induced development of TH1 cells producing high levels of IFN-γ in BALB/c but not C57BL/6 mice. J. Immunol. 160:1998;1708-1716.
56. Peel J.E., Voirol M.J., Kolly C., Gobet D., Martinod S. Induction of circulating tumor necrosis factor cannot be demonstrated during septicemic salmonellosis in calves. Infect. Immun. 58:1990;439-442.
57. Jotwani R., Tanaka Y., Watanabe K., Tanaka K., Kato N., Ueno K. Cytokine stimulation during Salmonella typhimurium sepsis in Itys mice. J. Med. Microbiol. 42:1995;348-352.
58. Keuter M., Dharmana E., Gasem M.H. Patterns of proinflammatory cytokines and inhibitors during typhoid fever. J. Infect. Dis. 169:1994;1306-1311.
59. Ciacci-Woolwine F., Kucera L.S., Richardson S.H., Iyer N.P., Mizel S.B. Salmonella activate tumor necrosis factor alpha production in a human promonocytic cell line via a released polypeptide. Infect. Immun. 65:1997;4624-4633.
60. Klimpel G.R., Shaban R., Niesel D.W. Bacteria-infected fibroblasts have enhanced susceptibility to the cytotoxic action of tumor necrosis factor. J. Immunol. 145:1990;711-717.
61. Nakano Y., Onozuka K., Terada Y., Shinomiya H., Nakano M. Protective effect of recombinant tumor necrosis factor-α in murine salmonellosis. J. Immunol. 144:1990;1935-1941.
62. Morrissey P.J., Charrier K., Vogel S.N. Exogenous tumor necrosis factor alpha and interleukin-1α increase resistance to Salmonella typhimurium: efficacy is influenced by the Ity and Lps loci. Infect. Immun. 63:1995;3196-3198.
63. Tite J.P., Dougan G., Chatfield S.N. The involvement of tumor necrosis factor in immunity to Salmonella infection. J. Immunol. 147:1991;3161-3164.
64. Mastroeni P., Arena A., Costa G.B., Liberto M.C., Bonina L., Hormaeche C.E. Serum TNFα in mouse typhoid and enhancement of a Salmonella infection by anti-TNFα antibodies. Microb. Pathogen. 11:1991;33-38.
65. Mastroeni P., Skepper J.N., Hormaeche C.E. Effect of anti-tumor necrosis factor alpha antibodies on histopathology of primary Salmonella infections. Infect. Immun. 63:1995;3674-3682.
66. Mastroeni P., Villareal-Ramos B., Hormaeche C.E. Role of T cells TNFα and IFNγ in recall of immunity to oral challenge with virulent Salmonellae in mice vaccinated with live attenuated aro- Salmonella vaccines. Microb. Pathogen. 13:1992;477-491.
67. Everest P., Roberts M., Dougan G. Susceptibility to Salmonella typhimurium infection and effectiveness of vaccination in mice deficient in the tumor necrosis factor alpha p55 receptor. Infect. Immun. 66:1998;3355-3364.
68. Mastroeni P., Villareal-Ramos B., Hormaeche C.E. Effect of late administration of anti-TNFα antibodies on a Salmonella infection in the mouse model. Microb. Pathogen. 14:1993;473-480.
69. Morrissey P.J., Charrier K. Interleukin-1 administration to C3H/HeJ mice after but not prior to infection increases resistance to Salmonella typhimurium. Infect. Immun. 59:1991;4729-4731.
70. Morrissey P.J., Charrier K. Treatment of mice with IL-1 before infection increases resistance to a lethal challenge with Salmonella typhimurium. J. Immunol. 153:1994;212-219.
71. Yamamoto Y., Klein T.W., Friedman H. Induction of cytokine granulocyte-macrophage colony-stimulating factor and chemokine macrophage inflammatory protein 2 mRNAs in macrophages by Legionella pneumophila or Salmonella typhimurium attachment requires different ligand-receptor systems. Infect. Immun. 64:1996;3062-3068.
72. Morrissey P.J., Charrier K. GM-CSF administration augments the survival of Ity-resistant A/J mice but not Ity-susceptible C57BL/6 mice to a lethal challenge with Salmonella typhimurium. J. Immunol. 144:1990;557-561.
73. Denich K., Börlin P., O'Hanley P.D., Howard M., Heath A.W. Expression of the murine interleukin-4 gene in an attenuated aroA strain of Salmonella typhimurium: persistence and immune response in BALB/c mice and susceptibility to macrophage killing. Infect. Immun. 61:1993;4818-4827.
74. Everest P., Allen J., Papakonstantinopoulou A., Mastroeni P., Roberts M., Dougan G. Salmonella typhimurium infections in mice deficient in interleukin-4 production. J. Immunol. 159:1997;1820-1827.
75. Ramsay A.J., Husband A.J., Ramshaw I.A. et al. The role of interleukin-6 in mucosal IgA antibody response in vivo. Science. 264:1994;561-563.
76. Klimpel G.R., Asuncion M., Haithcoat J., Niesel D.W. Cholera toxin and Salmonella typhimurium induce different cytokine profiles in the gastrointestinal tract. Infect. Immun. 63:1995;1134-1137.
77. Weinstein D.L., O'Neill B.L., Metcalf E.S. Salmonella typhi stimulation of human intestinal epithelial cells induces secretion of epithelial cell-derived interleukin-6. Infect. Immun. 65:1997;395-404.
78. Weinstein D.L., O'Neill B.L., Hone D.M., Metcalf E.S. Differential early interactions between Salmonella enterica serovar typhi and two other pathogenic Salmonella serovars with intestinal epithelial cells. Infect. Immun. 66:1998;2310-2318.
79. Dunstan S.J., Ramsay A.J., Strugnell R.A. Studies of immunity and bacterial invasiveness in mice given a recombinant Salmonella vector encoding murine interleukin-6. Infect. Immun. 64:1996;2730-2736.
80. Olivier M., Cook P., Desanctis J., Hel Z., Wojciechowski W., Reiner N.E., Skamene E., Radzioch D. Phenotypic difference between Bcgr and Bcgs macrophages is related to differences in protein-kinase-C-dependent signalling. Eur. J. Biochem. 251:1998;734-743.
81. Durbin J.E., Hackenmiller R., Simon M.C., Levy D.E. Targeted disruption of the mouse STAT1 gene results in compromised innate immunity to viral disease. Cell. 84:1996;443-450.
82. Meraz M.A., White J.M., Sheehan K.C.F. et al. Targeted disruption of the STAT1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell. 84:1996;431-442.